Arcutis Biotherapeutics, Inc. Balance Sheet
ARQT / Health Care|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Arcutis Biotherapeutics, Inc. had $433M in total assets and $189M in shareholders' equity as of FY2025. Total debt was $109M against $43M in cash, resulting in $66M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $42.9M | $71.3M | $88.4M | $53.6M | $96.4M | $65.1M | $63.3M | - |
| Accounts Receivable | $146.2M | $73.1M | $25.8M | $8.5M | $0 | - | - | - |
| Inventory | $22.6M | $14.5M | $13.1M | $7.5M | $0 | - | - | - |
| Current Assets | $411.2M | $335.8M | $330.4M | $437.4M | $402.8M | $292.8M | $106.5M | - |
| PP&E (Net) | $1.0M | $1.0M | $1.5M | $1.9M | $2.3M | $2.0M | $227.0K | - |
| Total Assets | $433.0M | $348.9M | $341.4M | $449.3M | $408.2M | $298.3M | $107.0M | - |
| Current Liabilities | $129.8M | $81.0M | $46.7M | $37.8M | $33.3M | $22.6M | $5.2M | - |
| Total Debt | $109.0M | $107.2M | $201.8M | $197.8M | $72.3M | $0 | - | - |
| Shareholders' Equity | $189.5M | $157.5M | $88.7M | $209.6M | $297.7M | $270.6M | -$65.0M | -$24.0M |